secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2026-03-24T23:59:59+00:00
Accession:  0001213900-26-033643
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix appoints David White CEO, adds Sammy Dorf to board
------------------------------------------------------------

- David White appointed CEO effective March 18, 2026; monthly salary $21,700 under employment agreement.
- Timothy Ramdeen resigned from board effective March 19, 2026; not due to any disagreement.
- Sammy Dorf appointed to board and audit committee effective March 19, 2026; brings capital markets and governance experience.
- Karina Fedasz remains interim CFO; her monthly compensation reduced by $5,000; Andrew Oakley's reduced by $26,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026033643/0001213900-26-033643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026033643/ea0283046-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-033643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer